Food & Drug Administration (FDA)
LATEST
Artificial Intelligence | Food & Drug Administration (FDA)
FDA Completes Landmark AI Review Pilot, Sets Ambitious Rollout
The FDA’s landmark AI-assisted scientific review pilot signals a transformative shift under Chief AI Officer Jeremy Walsh. What might exploratory discussions with OpenAI mean for regulatory oversight and transparency? #FDA #AI #RegulatoryInnovation #OpenAI
Read MoreMore Food & Drug Administration (FDA) Articles
Artificial Intelligence
FDA Completes Landmark AI Review Pilot, Sets Ambitious Rollout
The FDA’s landmark AI-assisted scientific review pilot signals a transformative shift under Chief AI Officer Jeremy Walsh. What might exploratory discussions with OpenAI mean for regulatory oversight and transparency? #FDA #AI #RegulatoryInnovation #OpenAI
Read MoreFood & Drug Administration (FDA)
In House Warrior: Vaccine Mandates & The Return to Office Dilemma
Lowell Pearson, office managing partner, and Natalie Holden, associate, with Hush Blackwell in Jefferson City, Missouri join host Richard Levick to discuss the challenging issues facing a return to the office, including employers’ ability to mandate vaccines, the landscape of state legislation and executive orders, what FDA approving of the vaccine would mean and the trend of early vaccine mandate lawsuits.
Read MoreFood & Drug Administration (FDA)
Vaccines: Where are We?
As the U.S. marches on with the two approved COVID-19 vaccines, it seems that the original plan to vaccinate 20 million people by the end of 2020 fell a little short. McNees Wallace & Nurick associate, Langdon Ramsburg, assesses where the situation stands and what comes next.
Read More